novartis ag-2nd line
(NOVNEE:SIX Swiss Ex)
David R. Epstein B.Sc., M.B.A.
Division Head of Novartis Pharmaceuticals and Member of Executive Committee, Novartis AG
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 6 different industries.|
As of Fiscal Year 2013
Mr. David R. Epstein, B.Sc., M.B.A. serves as Division Head of Novartis Pharmaceuticals at Novartis AG. Mr. Epstein serves as President of Novartis at Novartis Pharma K.K. He has been Head of Global Pharmaceuticals Division at Novartis AG and Novartis Vaccines and Diagnostics, Inc. since February 1, 2010. Mr. Epstein serves as President and Chief Executive Officer of Oncology and Molecular Diagnostics of Novartis Institutes for Biomedical Research, Inc. He served as ...
Lichtstrasse 35Phone: 41 61 324 11 11
Basel, Basel-Stadt 4056
Board Members Memberships*
Former Independent Director, Member of Governance & Nominating Committee and Member of Research, Regulatory & Clinical Committee
Columbia Business School
Rutgers, The State University of New Jersey
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Alan George Lafley||Chairman, Chief Executive Officer, President and Member of Proxy Committee|
The Procter & Gamble Company
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Kenneth C. Frazier||Chairman and Chief Executive Officer|
Merck & Co. Inc.
|Serge Weinberg||Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee|
|€700.0K||Compensation as of Fiscal Year 2013.|